Addimmune Overview

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

Addimmune General Information

Description

Developer of cell and gene therapy intended to develop an immune regulatory functional cure for HIV. The company's investigational cell therapy helps make gene modifications to immune cells to make them harder to infect by HIV and next-gen anti-HIV drugs to increase their efficacy or reduce side effects, enabling healthcare practitioners to provide treatments to patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9713 Key West Avenue
  • 5th Floor
  • Rockville, MD 20850
  • United States
+1 (301)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 9713 Key West Avenue
  • 5th Floor
  • Rockville, MD 20850
  • United States
+1 (301)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Addimmune Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private Completed Clinical Trials - Phase 1
3. Early Stage VC 01-Feb-2024 Completed Clinical Trials - Phase 1
2. Early Stage VC 30-Jun-2022 Completed Clinical Trials - Phase 1
1. Reverse Merger 09-Aug-2023 Cancelled Clinical Trials - Phase 1
To view Addimmune’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Addimmune Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cell and gene therapy intended to develop an immune regulatory functional cure for HIV. The company's inves
Biotechnology
Rockville, MD
6 As of 2024

Richmond, CA
 

Abingdon, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Addimmune Competitors (5)

One of Addimmune’s 5 competitors is Sangamo Therapeutics, a Formerly VC-backed company based in Richmond, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sangamo Therapeutics Formerly VC-backed Richmond, CA
Immunocore Holdings Formerly VC-backed Abingdon, United Kingdom
Gilead Formerly VC-backed Foster City, CA
ViiV Healthcare Corporate Backed or Acquired London, United Kingdom
Aelix Corporation Cassola, Italy
You’re viewing 5 of 5 competitors. Get the full list »

Addimmune Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Addimmune Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Gaingels Venture Capital Minority
ROC Venture Group Venture Capital Minority
Opus8 PE/Buyout Minority
Ossian Capital Venture Capital Minority
To view Addimmune’s complete investors history, request access »

Addimmune FAQs

  • Where is Addimmune headquartered?

    Addimmune is headquartered in Rockville, MD.

  • What is the size of Addimmune?

    Addimmune has 6 total employees.

  • What industry is Addimmune in?

    Addimmune’s primary industry is Biotechnology.

  • Is Addimmune a private or public company?

    Addimmune is a Private company.

  • What is Addimmune’s current revenue?

    The current revenue for Addimmune is .

  • How much funding has Addimmune raised over time?

    Addimmune has raised $50M.

  • Who are Addimmune’s investors?

    Gaingels, ROC Venture Group, Opus8, and Ossian Capital have invested in Addimmune.

  • Who are Addimmune’s competitors?

    Sangamo Therapeutics, Immunocore Holdings, Gilead, ViiV Healthcare, and Aelix are competitors of Addimmune.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process